Free product worth Rs 499 on all myUpchar products
Olmegraf 40 Tablet is a commercial drug that is prescribed in the form of Tablet. It is primarily used for the treatment of High BP. The alternative uses of Olmegraf 40 Tablet have also been explained below.
The optimal dosage of Olmegraf 40 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
The most common side effects of Olmegraf 40 Tablet are Upper respiratory tract infection. While these are the most often observed Olmegraf 40 Tablet side effects, there are can be others also. These have been listed below. Usually, these side effects of Olmegraf 40 Tablet go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Olmegraf 40 Tablet is Severe for pregnant women and Mild for women who are breastfeeding. In addition, Olmegraf 40 Tablet's effects on the liver, heart and kidney are discussed below in the Olmegraf 40 Tablet related warnings section.
Olmegraf 40 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension) are examples of such conditions. The section on Olmegraf 40 Tablet contraindications lists all such conditions.
Besides this, Olmegraf 40 Tablet may also have severe interaction with some medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Olmegraf 40 Tablet is considered not safe while driving, and is not addictive.
Olmegraf 40 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Is the use of Olmegraf 40 Tablet safe for pregnant women?
Pregnant women may get severe side effects after taking Olmegraf. If you are pregnant, do not take Olmegraf without a doctor's advice.
Is the use of Olmegraf 40 Tablet safe during breastfeeding?
Olmegraf has been seen to have minimal side effects on breastfeeding women.
What is the effect of Olmegraf 40 Tablet on the Kidneys?
Olmegraf may have mild side effects on the kidneys.
What is the effect of Olmegraf 40 Tablet on the Liver?
Side effects of Olmegraf rarely affect the liver.
What is the effect of Olmegraf 40 Tablet on the Heart?
Side effects of Olmegraf rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Olmegraf 40 Tablet unless your doctor advises you to do so -
Is this Olmegraf 40 Tablet habit forming or addictive?
Olmegraf 40 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Olmegraf 40 Tablet, you should not drive or work on any heavy machine, as Olmegraf 40 Tablet can make you drowsy.
Is it safe?
Olmegraf 40 Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Olmegraf 40 Tablet cannot treat any kind of mental disorder.
Interaction between Food and Olmegraf 40 Tablet
Taking Olmegraf 40 Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Olmegraf 40 Tablet
Consuming Olmegraf 40 Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
